Please note: The information displayed on this page might be outdated.
Arcus Biosciences: Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies. Arcus has several programs targeting important immuno-oncology pathways, including a dual adenosine receptor antagonist AB928, which is in a Phase 1/1b program to evaluate AB928 in combination with other agents in multiple tumor types, and an anti-PD-1 antibody AB122, which is being evaluated in a Phase 1 trial and is being tested in combination with Arcus’s other product candidates. Arcus’s other programs include AB154, an anti-TIGIT antibody, which is in a Phase 1 trial to evaluate AB154 as monotherapy and in combination with AB122, and AB680, a small molecule inhibitor of CD73, which has entered clinical development. Arcus has extensive in-house expertise in medicinal chemistry, immunology, biochemistry, pharmacology and structural biology.
Based in...
US - Pacific
Disease Space
Immuno-Oncology, Oncology
Public, USA
Market Cap
1B +
3928 Point Eden Way
Hayward, CA 94545
United States

Company Participants at Class of 2018 Biotech IPO Investor Day

  • Terry Rosen, CEO

Top 10 Holders of Arcus Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
PFM Health Sciences LP 7.36 3,373,460 82.24 Stakes 10/29/20
Tavistock Life Sciences Co. (Investment Management) 4.66 3,022,391 73.69 Stakes 2/3/20
BVF, Inc. 5.66 2,597,222 63.32 13F 9/30/20
State Street Corp. 5.49 2,518,468 61.40 13F 9/30/20
Fidelity Management & Research Co. LLC 5.13 2,350,942 57.32 13F 9/30/20
The Vanguard Group, Inc. 4.64 2,135,580 52.07 Funds 10/31/20
Boxer Capital LLC 4.55 2,084,883 50.83 13F 9/30/20
Vanguard Group, Inc. (Subfiler) 4.54 2,079,849 50.71 13F 9/30/20
Invus Financial Advisors LLC 4.02 1,842,077 44.91 13F 9/30/20
Ecor1 Capital LLC 3.95 1,810,000 44.13 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.